Kembali ke Daftar Obat
Panduan penyiapan dan pemberian terapi medikasi
Panduan penyiapan dan pemberian terapi medikasi
Ceftriaxone
Penyiapan
Sediaan
- 250mg
- 500mg
- 1gr
- 2gr
Rekomendasi Pengenceran (Konsentrasi)
- injeksi IV: 10-40mg/ml (250mg dalam 6,25cc, 500mg dalam 12,5cc, 1gr dalam 25cc, 2gr dalam 50cc)
- injeksi IM: 250 dalam 1ml, 500mg dalam 2cc, 1gr dalam 4cc, 2gr dalam 7,5cc
Pelarut
- D5%
- NaCl 0.9%
- RL
- WI
Pemberian
Rekomendasi Akses
IV
IM
IM
Rekomendasi Durasi Pemberian
intermiten dalam 15-30menit
Stabilitas Obat Setelah Rekonstruksi
24 jam dalam suhu 25C
Keamanan
pH
6,7
pH risiko rendah (5,0-7,5)
Osmolaritas Sesudah Pengenceran
konsentrasi 50mg/ml dalam NS 0,9% = 364mOsm/kg
Osmolaritas rendah (<600)
Phlebitis
Tidak
Inkompatibilitas
-
Aminophylline
-
Calcium chloride
-
Calcium gluconate
-
Clindamycin phosphate
-
Gentamicin sulfate
-
Linezolid
-
Theophylline,
-
Lidocaine HCl
-
Amsacrine
-
Anakinra
-
Azithromycin
-
Caspofungin acetate
-
Filgrastim
-
Fluconazole
-
Isavuconazium sulfate
-
Lebetalol HCl
-
Pentamidine isethionate
-
Vancomycin HCl
- Vinorelbine tartate
Klasifikasi GHS
Irritant
Health Hazard
Manifestasi GHS
315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
H317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin]
H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
H334 (100%): May cause allergy or asthma symptoms or breathing difficulties if inhaled [Danger Sensitization, respiratory]
H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
H317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin]
H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
H334 (100%): May cause allergy or asthma symptoms or breathing difficulties if inhaled [Danger Sensitization, respiratory]
H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
Sumber
- American Society of Health-System Pharmacists. 2021. ASHP® Injectable Drug Information: A Comprehensive Guide to Compatibility and Stability. 2021 Edition. eBook. American Society of Health-System Pharmacists. ISBN: 978-1-58528-690-4. doi.org/10.37573/9781585286850
- https://pubchem.ncbi.nlm.nih.gov/compound/5479530